Ajay Madan is senior director of preclinical development at Neurocrine. He has worked with pharmaceutical companies in characterization and risk assessment of metabolism liabilities of new chemical entities. He has 13+ years of industry experience with in vitro drug metabolism, pharmacokinetics and toxicology.